CHICAGO, Nov. 29, 2021 /PRNewswire/ -- Volpara Health, (ASX: VHT) showcases its integrated platform for the delivery of personalized breast care, at the 107th Annual Radiological Society of North America (RSNA) meeting, November 28-December 2, 2021 (South Hall #2160).
Volpara's AI-driven breast software tools are built on a database of more than 50 million mammogram images, enabling clinicians to provide a high-quality, optimized, and personalized cancer screening experience. The software tools provide a smooth, integrated IT workflow along with objective evidence for clinical decision support. The software offerings range from enterprise-wide quality analytics to risk assessment for individual women aligned with all major US guidelines.
Identification and Management of High-Risk Patients in every Screening Center
Ad Statistics
Times Displayed: 2130
Times Visited: 4 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money.
While mammography remains the gold standard for the early detection of breast cancer, millions of women are impacted by breast cancer every year, with more than 680,000 deaths worldwide. In an effort to save more families from cancer, medical societies including NCCN, ACR, SBIT, SBI and ASBrS, are all recommending a shift from age-based screening to risk-stratified screening programs that aim to provide women the right test at the right time, leading to earlier cancer detection, critical in reducing treatment costs and increasing the chances of survival.
Demonstrated as a fully integrated product at RSNA for the first time following the acquisition of CRA Health, the Volpara Risk Pathways™ software enables radiologists to leverage existing workflows to identify, manage and track high-risk patients who may benefit from intervention. Using patient data available via mammography reporting systems or EHRs, Volpara's market-leading breast cancer risk assessment software, which is used to perform more than 2 million risk assessments every year, helps clinicians confidently make informed decisions for triaging patients to supplemental imaging and/or genetic testing based on their individual risk profile.
New Training and Recognition Program for Exam Quality and Clinical Improvements
Optimizing exam quality plays an important part in cancer detection. Volpara Analytics™ software provides automated and objective assessment of image quality on every mammogram and provides technologists with performance feedback. The new version of Volpara Analytics (v3.0) software includes improved reporting, analysis and workflow features.
